582
Views
24
CrossRef citations to date
0
Altmetric
Original Research

Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain

, MD PhD, , MD PhD, , MD PhD, , MD & , MD
Pages 1049-1052 | Published online: 19 Apr 2010

Bibliography

  • Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-70
  • Andersson GB. Epidemiological features of chronic low back pain. Lancet 1999;354:581-5
  • Skljarevski V, Ossanna M, Liu-Seifert H, A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009;16:1041-8
  • Krell HV, Leuchter AF, Cook IA, Abrams M. Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics 2005;46:379-84
  • Perrot S, Javier RM, Marty M, Is there any evidence to support the use of antidepressants in painful rheumatological conditions? Systematic review of pharmacological and clinical studies. Rheumatology 2008;47:1117-23
  • Staiger TO, Gaster B, Sullivan MD, Deyo RA. Systematic review of antidepressants in the treatment of chronic low back pain. Spine 2003;28:2540-5
  • Kroenke K, Bair MJ, Damush TM, Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301:2099-110
  • Delgado PL. Common pathways of depression and pain. J Clin Psychol 2004;65(Suppl 12):16-9
  • Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000;32:305-16
  • Atkinson JH, Slater MA, Wahlgreen DR, Effects of noradrenergic and serotoninergic antidepressants on chronic low back pain. Pain 1999;83:137-45
  • Aigner M, Bach M. The antinociceptive effects of antidepressants-noradrenergic versus serotoninergic modes of action? Pain 2000;88:217
  • Muller JE, Wentzel I, Koen L, Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial. Int Clin Psychopharmacol 2008;23:43-8
  • Turk DC, Dworkin RH, Allen RR, Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:377-45
  • Dworkin RH, Turk DC, Farrar JT, Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19
  • Spitzer W, LeBlanc F, Dupuis M. Scientific approach to the assessment and management of activity-related spinal disorders (the Quebec Task Force). Spine 1987;12:S16-21
  • Guy W. Clinical Global Impressions, ECDEU Assessment Manual for Psychopharmacology. US Government Printing Office, Washington, DC; 1976
  • Fava M, Mallinckrodt CH, Detke MJ, The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004;65:521-30
  • Atkinson JH, Slater MA, Williams RA, A placebo-controlled randomized clinical trial of nortriptyline for chronic low back pain. Pain 1998;76:287-96
  • Max MB. Antidepressants as analgesics. In: Fields HL, Liebeskind JC, editors, Progress in pain research and management. Volume 1. IASP Press, Seattle, WA; 1994. p. 229-46

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.